NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7 | +75.0% | 6,100 | +22.0% | 0.00% | – |
Q1 2024 | $4 | -50.0% | 5,000 | -66.2% | 0.00% | – |
Q3 2023 | $8 | +14.3% | 14,800 | +6.5% | 0.00% | – |
Q2 2023 | $7 | -36.4% | 13,900 | +178.0% | 0.00% | – |
Q4 2022 | $11 | -100.0% | 5,000 | -58.3% | 0.00% | – |
Q3 2022 | $38,000 | -68.6% | 12,000 | -62.5% | 0.00% | – |
Q2 2022 | $121,000 | -97.0% | 32,000 | -95.8% | 0.00% | -100.0% |
Q1 2022 | $4,067,000 | +942.8% | 754,700 | +2511.4% | 0.00% | – |
Q4 2021 | $390,000 | +28.7% | 28,900 | +67.1% | 0.00% | – |
Q3 2021 | $303,000 | +2.4% | 17,300 | 0.0% | 0.00% | – |
Q2 2021 | $296,000 | +20.3% | 17,300 | +13965.0% | 0.00% | – |
Q1 2021 | $246,000 | -72.7% | 123 | -76.8% | 0.00% | -100.0% |
Q4 2020 | $901,000 | -22.1% | 530 | -24.0% | 0.00% | -50.0% |
Q3 2020 | $1,156,000 | -29.8% | 697 | -2.0% | 0.00% | -33.3% |
Q2 2020 | $1,646,000 | +22.0% | 711 | -6.0% | 0.00% | +50.0% |
Q1 2020 | $1,349,000 | -42.6% | 756 | -30.6% | 0.00% | -60.0% |
Q4 2019 | $2,350,000 | -12.1% | 1,089 | -25.8% | 0.01% | -37.5% |
Q3 2019 | $2,673,000 | +11.0% | 1,468 | +116.8% | 0.01% | +14.3% |
Q2 2019 | $2,408,000 | +31.3% | 677 | +24.0% | 0.01% | +40.0% |
Q1 2019 | $1,834,000 | +106.8% | 546 | +102.2% | 0.01% | +66.7% |
Q4 2018 | $887,000 | -78.2% | 270 | -59.5% | 0.00% | -76.9% |
Q3 2018 | $4,066,000 | +17.1% | 667 | -6.2% | 0.01% | -7.1% |
Q2 2018 | $3,471,000 | +6705.9% | 711 | +625.5% | 0.01% | +600.0% |
Q1 2018 | $51,000 | +27.5% | 98 | -80.6% | 0.00% | 0.0% |
Q4 2017 | $40,000 | +344.4% | 505 | +193.6% | 0.00% | – |
Q3 2017 | $9,000 | -43.8% | 172 | -58.8% | 0.00% | -100.0% |
Q2 2017 | $16,000 | +23.1% | 417 | -48.8% | 0.00% | 0.0% |
Q1 2017 | $13,000 | -72.9% | 814 | +81.7% | 0.00% | -66.7% |
Q4 2016 | $48,000 | +433.3% | 448 | +460.0% | 0.00% | +200.0% |
Q3 2016 | $9,000 | +350.0% | 80 | +17.6% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 68 | +61.9% | 0.00% | – |
Q1 2016 | $2,000 | – | 42 | -23.6% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 55 | -9.8% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 61 | -4.7% | 0.00% | – |
Q2 2015 | $2,000 | -88.2% | 64 | -55.2% | 0.00% | -100.0% |
Q1 2015 | $17,000 | -41.4% | 143 | -44.6% | 0.00% | -50.0% |
Q4 2014 | $29,000 | – | 258 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 817 | $2,685,000 | 0.59% |
GROUP ONE TRADING, L.P. | 85,800 | $2,820,000 | 0.02% |
SIMPLEX TRADING, LLC | 270 | $887,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 40,000 | $1,315,000 | 0.00% |